Drug intelligence / Profile preview

diclofenac etalhyaluronate

Development stage
Unknown
Lead developer
Ono Pharmaceutical
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraarticular
01

Overview

**Diclofenac etalhyaluronate** is a locally sustained intra-articular anti-inflammatory treatment for osteoarthritis developed by Seikagaku. It is a single covalent hyaluronic acid-diclofenac conjugate in which diclofenac is linked to high-molecular-weight hyaluronic acid through a 2-aminoethanol linker. Following injection into the joint, the conjugate provides sustained local release of diclofenac, inhibiting cyclooxygenase-1 and cyclooxygenase-2 and reducing prostaglandin-mediated pain and inflammation. It is approved in Japan as an intra-articular injection for knee osteoarthritis and has also been evaluated for osteoarthritis affecting other large joints.

Brand names
JoycleJOYCLU
Other names
DF-HA
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on diclofenac etalhyaluronate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac etalhyaluronate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call